Richard A. Gonzalez
CHAIRMAN OF THE BOARD AND CEO at AbbVie Inc. · b. 1954
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: AbbVie Inc., 3 years.
Chief executive roles
Solid · grade C
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 35% of the scoring weight is on file.
- Revenue growth 20%
- 80
- Earnings growth 15%
- 36
10.4% a year in revenue
-1.9% a year in earnings per share
35% of the scoring weight is on file. Figures cover December 2012 – December 2023.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AbbVie Inc. February 14, 202492.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2025 | AbbVie Inc. | Gift | −2,450 | — | — |
| Mar 3, 2025 | AbbVie Inc. | Open-market sale | −6,168 | $210.53 | $1,298,549 |
| Feb 28, 2025 | AbbVie Inc. | Shares withheld for tax | −73,209 | $205.02 | $15,009,309 |
| Feb 28, 2025 | AbbVie Inc. | Open-market sale | −92,460 | $205.11 | $18,964,471 |
| Feb 13, 2025 | AbbVie Inc. | Grant or award | +80,945 | — | — |
| Feb 13, 2025 | AbbVie Inc. | Grant or award | +33,208 | — | — |
| Feb 13, 2025 | AbbVie Inc. | Grant or award | +30,298 | — | — |
| Feb 13, 2025 | AbbVie Inc. | Grant or award | +27,386 | — | — |
| Sep 30, 2024 | AbbVie Inc. | Gift | −5,243 | — | — |
| Sep 30, 2024 | AbbVie Inc. | Gift | −15,729 | — | — |
| Sep 30, 2024 | AbbVie Inc. | Gift | −36,698 | — | — |
| Aug 5, 2024 | AbbVie Inc. | Open-market sale | −66,500 | $186.52 | $12,403,580 |
| Jul 17, 2024 | AbbVie Inc. | Option exercise | +87,050 | $61.36 | $5,341,388 |
| Jul 17, 2024 | AbbVie Inc. | Option exercise | +119,418 | $79.02 | $9,436,410 |
| Jul 17, 2024 | AbbVie Inc. | Option exercise | +76,377 | $93.50 | $7,141,250 |
Questions about Richard A. Gonzalez
What boards is Richard A. Gonzalez on?
Richard A. Gonzalez sits on the board of AbbVie Inc.
Has Richard A. Gonzalez been a CEO?
Yes — Richard A. Gonzalez was CEO of AbbVie Inc. (2013 – 2024).
How long has Richard A. Gonzalez served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.